Nivolumab for treating patients with occupational cholangiocarcinoma.
Tanaka S, Umemoto K, Kubo S, Sato Y, Mimaki S, Tsuchihara K, Takemura S, Shinkawa H, Mori A, Ikeda M.
Tanaka S, et al. Among authors: kubo s.
J Hepatobiliary Pancreat Sci. 2022 Nov;29(11):1153-1155. doi: 10.1002/jhbp.1215. Epub 2022 Aug 8.
J Hepatobiliary Pancreat Sci. 2022.
PMID: 35793385